Cargando…
Liver Transplantation in a Patient with Acquired Dysfibrinogenemia Who Presented with Subdural Hematoma: A Case Report
Autores principales: | Acar, Şencan, Güngör, Gökhan, Dayangaç, Murat, Diz-Küçükkaya, Reyhan, Tokat, Yaman, Akyıldız, Murat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774367/ https://www.ncbi.nlm.nih.gov/pubmed/28587999 http://dx.doi.org/10.4274/tjh.2017.0045 |
Ejemplares similares
-
Role of pre-transplant 18F-FDG PET/CT in predicting hepatocellular carcinoma recurrence after liver transplantation
por: Yaprak, Onur, et al.
Publicado: (2018) -
The Predictive and Prognostic Significance of c-erb-B2, EGFR, PTEN, mTOR, PI3K, p27, and ERCC1 Expression in Hepatocellular Carcinoma
por: Bassullu, Nuray, et al.
Publicado: (2012) -
Liver transplantation in hepatic myelopathy
por: Acar, Sencan, et al.
Publicado: (2022) -
Living Donor Liver Transplantation: The Optimal Curative Treatment for Hepatocellular Carcinoma Even Beyond Milan Criteria
por: Alim, Altan, et al.
Publicado: (2021) -
Pseudohomozygous dysfibrinogenemia
por: Peck, Rachel C., et al.
Publicado: (2021)